CSIMarket
 


Endologix Inc  (ELGX)
Other Ticker:  
 

Endologix Inc's Leverage Ratio

ELGX's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to net new borrowings of 5.23%, Leverage Ratio fell to 14.86, a new company high.

Within Medical Equipment & Supplies industry in the second quarter 2020, 177 other companies have achieved lower Leverage Ratio than Endologix Inc in the II Quarter 2020. While Leverage Ratio total ranking has improved so far in the second quarter 2020 to 4394, from total ranking in the first quarter 2020 at 4426 .

Explain Leverage Ratio?
Who are ELGX Customers?
What are ELGX´s Total Liabilities?


ELGX Leverage Ratio (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Equity Change -60.57 % 175.14 % 61.07 % 61.75 % 81.89 %
Y / Y Total Liabilities Change 67.43 % 48.57 % -3.99 % -12.52 % -14.25 %
Leverage Ratio MRQ 14.86 7.53 3.81 3.55 3.5
ELGX's Total Ranking # 4394 # 4426 # 3413 # 2355 # 2854
Seq. Equity Change -46.71 % -16.49 % -8.5 % -3.18 % 271.91 %
Seq. Total Liabilities Change 5.23 % 64.93 % -1.79 % -1.78 % -6.63 %



Leverage Ratio second quarter 2020 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 178
Healthcare Sector # 836
Overall Market # 4394


Leverage Ratio Statistics
High Average Low
14.86 3.32 0.67
(Jun 30 2020)   (Jun 30 2012)




Financial Statements
Endologix Inc's Equity $ 28 Millions Visit ELGX's Balance sheet
Endologix Inc's Total Liabilities $ 422 Millions Visit ELGX's Balance sheet
Source of ELGX's Sales Visit ELGX's Sales by Geography


Cumulative Endologix Inc's Leverage Ratio

ELGX's Leverage Ratio for the trailling 12 Months

ELGX Leverage Ratio

(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Equity TTM Growth -60.57 % 175.14 % 61.07 % 61.75 % 81.89 %
Y / Y Total Liabilities TTM Growth 67.43 % 48.57 % -3.99 % -12.52 % -14.25 %
Leverage Ratio TTM 6.1 4.42 4.5 5.09 6.08
Total Ranking TTM # 4030 # 49 # 65 # 75 # 86
Seq. Equity TTM Growth -46.71 % -16.49 % -8.5 % -3.18 % 271.91 %
Seq. Total Liabilities TTM Growth 5.23 % 64.93 % -1.79 % -1.78 % -6.63 %


On the trailing twelve months basis Due to the net new borrowings of 5.23% during the trailing twelve months finishing in the II Quarter 2020, cumulativeLeverage Ratio improved to 6.1, above the Endologix Inc's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 165, during the past 12 months, other companies have achieved lower Leverage Ratio than Endologix Inc. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the II Quarter 2020, compared to the prior period, from 49 to 4030.

Explain Leverage Ratio?
Who are ELGX Customers?
What are ELGX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 166
Healthcare Sector # 779
Within the Market # 4030


trailing twelve months Leverage Ratio Statistics
High Average Low
7.76 2.93 0.94
(Mar 31 2019)   (March 31, 2015)




Companies with similar Leverage Ratio in the quarter ending Jun 30 2020, within Medical Equipment & Supplies Industry Leverage RatioJun 30 2020 MRQ Total LiabilitiesJun 30 2020 MRQ Equity
American International Holdings Corp   23.46 $ 2.641  Millions$ 0.113  Millions
Biolase Inc   20.20 $ 26.447  Millions$ 1.309  Millions
Clearpoint Neuro Inc   16.19 $ 21.693  Millions$ 1.340  Millions
Endologix Inc  14.86 $ 422.285  Millions$ 28.417  Millions
Envveno Medical Corporation  9.11 $ 3.364  Millions$ 0.369  Millions
Alphatec Holdings Inc   8.74 $ 164.512  Millions$ 18.822  Millions
Vaso Corporation  8.26 $ 32.948  Millions$ 3.987  Millions
Yunhong Green Cti Ltd   8.18 $ 22.547  Millions$ 2.756  Millions
Conformis inc   7.01 $ 59.192  Millions$ 8.443  Millions
Sientra Inc   6.66 $ 147.087  Millions$ 22.089  Millions
Owens and Minor inc  6.54 $ 2,583.394  Millions$ 395.162  Millions
Accuray Incorporated  5.96 $ 378.994  Millions$ 63.635  Millions
Mimedx Group Inc   5.60 $ 128.052  Millions$ 22.860  Millions
Harvard Apparatus Regenerative Technology Inc   5.01 $ 1.152  Millions$ 0.230  Millions
The Pennant Group Inc   4.69 $ 386.745  Millions$ 82.501  Millions
Nemaura Medical Inc   3.55 $ 6.958  Millions$ 1.960  Millions
Plus Therapeutics Inc   3.17 $ 10.465  Millions$ 3.300  Millions
3m Company  3.08 $ 33,615.000  Millions$ 10,915.000  Millions

Date modified: 2023-03-24T01:06:23+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com